Efficacy and Safety of Second-Line Axitinib in Octogenarians With Metastatic RCC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Efficacy and Safety of Second-Line Axitinib in Octogenarians With Metastatic Renal Cell Carcinoma
J Geriatr Oncol 2020 Dec 30;[EPub Ahead of Print], Y Nakai, A Takeuchi, T Osawa, T Kojima, T Hara, M Sugimoto, M Eto, K Minami, K Ueda, M Ozawa, M Uemura, Y Miyauchi, K Ohba, A Kashiwagi, M Murakami, T Sazuka, H Yasumoto, S Morizane, Y Kawasaki, D Morooka, T Shimazui, Y Yamamoto, H Nakagomi, R Tomida, YM Ito, S Murai, H Kitamura, H Nishiyama, N ShinoharaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.